Target intelligence / Profile preview

Tight junction integrity

Molecular classification
Other
01

Overview

Tight junction integrity refers to the structural and functional stability of the zonula occludens, a specialized cell-cell adhesion complex that seals the paracellular space between epithelial or endothelial cells (StatPearls, 2023). These junctions are composed of transmembrane proteins, including claudins, occludin, and junctional adhesion molecules (JAMs), which interact with intracellular scaffold proteins like zonula occludens-1 (ZO-1) to link the barrier to the actin cytoskeleton (PubMed, 2021). The primary biological function of tight junction integrity is to maintain a selective permeable barrier, regulating the transport of ions and solutes while preventing the entry of pathogens and toxins into the systemic circulation (NIH, 2022). Loss of integrity is a hallmark of various pathologies, including inflammatory bowel disease, celiac disease, and blood-brain barrier breakdown in neurodegenerative disorders (PubMed, 2020). Pharmacological intervention typically focuses on stabilizing these complexes or inhibiting signaling molecules like zonulin that trigger junction disassembly (PubChem, 2023). For example, larazotide acetate is a peptide that acts as a zonulin antagonist to reduce intestinal permeability in celiac disease patients (PubMed, 2022). Maintaining this integrity is crucial for tissue homeostasis, as its disruption can lead to chronic inflammation and systemic immune activation (NIH, 2022).

Other names
Epithelial barrier functionParacellular barrierZonula occludens integrityMucosal barrier integrity
02

Mechanism of action

Modulation of paracellular permeability through the regulation of transmembrane protein assembly (e.g., claudins, occludin) and the inhibition of zonulin-mediated junction disassembly.

03

Biological functions

Barrier functionParacellular transport regulationCell polarity maintenanceInnate immune response
04

Disease associations

Inflammatory bowel diseaseCeliac diseaseCancer metastasisBlood-brain barrier dysfunctionSepsisType 1 diabetes
05

Safety considerations

Risk of systemic absorption of luminal toxinsImpaired nutrient uptakeTissue-specific barrier disruptionPotential for promoting tumor cell intravasation
06

Interacting drugs

Larazotide acetate

4 more in the full profile.

07

Biomarkers

Transepithelial electrical resistance (TEER)Serum zonulin levelsLactulose-to-mannitol ratioClaudin-3 expressionFecal calprotectin

Beyond the preview

Go deeper on Tight junction integrity.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tight junction integrity.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call